Bergenbio Asa Stock Quote 0RU5 - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

4,600.00

Bid

0.00

Ask

0.00

Volume

431

0.00 Day's Range 0.00

4,600.00 52 Week Range 4,600.00

Market Cap

12.368T

Previous Close

4,600.00

Open

Last Trade

257

9.667

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,126

Shares Outstanding

2,688,689,000

Dividend Yield

PE Ratio

-64,971.75

Earnings Per Share (EPS)

-0.07

Revenue

354k

Net Profit

-190.4M

Sector

Meas & Controlling Dev, Nec

Industry

Meas & Controlling Dev, Nec

Website

www.bergenbio.com

Headquarters

Bergen, Nor

Founded

Bergenbio Asa is listed in the Meas & Controlling Dev sector of the London Stock Exchange with ticker 0RU5. The last closing price for Bergenbio Asa was kr4,600. Over the last year, Bergenbio Asa shares have traded in a share price range of kr 4,600.00 to kr 4,600.00.

Bergenbio Asa currently has 2,688,689,000 shares outstanding. The market capitalization of Bergenbio Asa is kr12.37 trillion. Bergenbio Asa has a price to earnings ratio (PE ratio) of -64971.75.

BerGenBio Appoints Olav Hellebø as CEO

BerGenBio Appoints Olav Hellebø as CEO PR Newswire BERGEN, Norway, Nov. 20, 2024 BERGEN, Norway, Nov. 20, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical...

BerGenBio Appoints Olav Hellebø as CEO

BerGenBio Appoints Olav Hellebø as CEO PR Newswire BERGEN, Norway, Nov. 20, 2024 BERGEN, Norway, Nov. 20, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical...

BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer

BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer PR Newswire BERGEN, Norway, Aug. 22, 2023...

BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer

BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer PR Newswire BERGEN, Norway, Aug. 22, 2023...

BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue

BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue PR Newswire BERGEN, Norway, May 26, 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR...

BerGenBio ASA: Proposed partially underwritten rights issue

BerGenBio ASA: Proposed partially underwritten rights issue PR Newswire BERGEN, Norway, April 25, 2023 NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES...

BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR

BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR PR Newswire BERGEN, Norway, April 18, 2023 In addition to STK11 mutations, KEAP1m identified as being associated with...

BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR

BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR PR Newswire BERGEN, Norway, April 18, 2023 In addition to STK11 mutations, KEAP1m identified as being associated with...

BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations PR Newswire BERGEN, Norway, March 9, 2023 - Global...

BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations PR Newswire BERGEN, Norway, March 9, 2023 - Global...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	4600	4600	4600	501	4600	DE
4	4600	4600	4600	320	4600	DE
12	4600	4600	4600	1126	4600	DE
26	4600	4600	4600	857	4600	DE
52	4600	4600	4600	33030	4600	DE
156	4600	4600	4600	76232	4600	DE
260	4600	4600	4600	47604	4600	DE

0RU5 - Frequently Asked Questions (FAQ)

What is the current Bergenbio Asa share price?

The current share price of Bergenbio Asa is kr 4,600.00

How many Bergenbio Asa shares are in issue?

Bergenbio Asa has 2,688,689,000 shares in issue

What is the market cap of Bergenbio Asa?

The market capitalisation of Bergenbio Asa is NOK 12.37T

What is the 1 year trading range for Bergenbio Asa share price?

Bergenbio Asa has traded in the range of kr 4,600.00 to kr 4,600.00 during the past year

What is the PE ratio of Bergenbio Asa?

The price to earnings ratio of Bergenbio Asa is -64.97k

What is the cash to sales ratio of Bergenbio Asa?

The cash to sales ratio of Bergenbio Asa is 46M

What is the reporting currency for Bergenbio Asa?

Bergenbio Asa reports financial results in NOK

What is the latest annual turnover for Bergenbio Asa?

The latest annual turnover of Bergenbio Asa is NOK 354k

What is the latest annual profit for Bergenbio Asa?

The latest annual profit of Bergenbio Asa is NOK -190.4M

What is the registered address of Bergenbio Asa?

The registered address for Bergenbio Asa is M��LLENDALSBAKKEN 9, BERGEN, 5009

What is the Bergenbio Asa website address?

The website address for Bergenbio Asa is www.bergenbio.com

Which industry sector does Bergenbio Asa operate in?

Bergenbio Asa operates in the MEAS & CONTROLLING DEV, NEC sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TBLSTinybuild Inc.	6.50p (44.44%)	20k
WEBWebis Holdings Plc	0.075p (36.36%)	173.73k
REVBRevolution Beauty Group Plc	18.10p (29.29%)	2.81M
AMGAtlas Metals Group Plc	12.25p (28.95%)	456.51k
SYMESupply@me Capital Plc	0.0043p (22.86%)	261.33M
POLBPoolbeg Pharma Plc	4.15p (-41.96%)	28.51M
MILAMila Resources Plc	0.275p (-21.43%)	1.92M
S247Smarttech247 Group Plc	8.50p (-20.56%)	338.15k
THRUThruvision Group Plc	6.50p (-18.75%)	175.99k
QUIZQuiz Plc	0.62p (-16.78%)	147.62k
DGIDg Innovate Plc	0.025p (11.11%)	861.93M
TRPTower Resources Plc	0.0375p (4.17%)	425.3M
CPXCap-xx Limited	0.18p (16.13%)	317.62M
NTVONativo Resources Plc	0.0019p (0.00%)	292.58M
SYMESupply@me Capital Plc	0.0043p (22.86%)	261.33M